Verb Biotics, a microbiome innovation company, today announced that it will be participating as a next-generation biotech innovator at Ferment, Ginkgo Bioworks’ annual synthetic biology ...

These engineered organisms, called Synthetic Biotics, are being investigated as treatments for metabolic and immunologic diseases like phenylketonuria (PKU), homocystinuria (HCU), enteric ...

The rapid advancement of these potential biotherapeutics, called Synthetic Biotics, has been enabled by Synlogic’s reproducible, target-specific drug design. Synlogic uses programmable ...

“The field of IBD presents a clear need for therapeutic innovation, and there is a compelling fit with the disease biology and the locally acting, gut-restricted approach of Synthetic Biotics ...

Examples of forward-looking statements, include, but are not limited to, statements regarding the potential of Synlogic's approach to Synthetic Biotics to develop therapeutics to address a wide ...

"The advancement of SYNB2081 and SYNB1353 are clear indicators of the transformative platform Synlogic has created to develop new Synthetic Biotics through synthetic biology," said Patrick Boyle ...